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Abstract
Background: Echocardiographic assessment of left ventricular (LV) size and function
using area-based indices and volumetric estimates is not well established in horses.
Objective: To report reference intervals and measurement variability for uni-, 2-, and
3-dimensional echocardiographic indices of LV size and systolic function in
Warmblood horses and to provide proof of concept for allometric scaling of variables
to body weight. Unidimensional indices were to be compared to area-based indices
and LV volume estimates to establish their clinical use.
Animals: Thirty healthy Warmblood horses and 70 Warmblood horses with a primary
diagnosis of mitral regurgitation or aortic regurgitation.
Methods: Echocardiographic indices of LV size and systolic function were measured
using an existing echocardiography database. Weight-related variables were scaled
to body weight (BWT). Reference intervals and measurement variability were calcu-
lated, the influence of valvular regurgitation on LV size and function was investigated
and agreement between different variables for detection of reduced, normal, and
increased LV size and systolic function was assessed.
Results: Reference values for healthy Warmblood horses were reported. Measure-
ment variability was sufficiently low for clinical use of all variables. Allometric scaling
was effective to correct diastolic LV dimensions and cardiac output for differences in
BWT. Various echocardiographic indices resulted in different conclusions regarding
identification of LV enlargement and systolic dysfunction in healthy horses and
horses with valvular regurgitation.
Conclusions and Clinical Importance: Echocardiographic assessment of LV size and
systolic function should include joint assessment of multiple uni- and
Abbreviations: 2D, 2-dimensional; AAD, aortic annular diameter; AMM, anatomical motion mode; ANOVA, analysis of variance; AR, aortic regurgitation; BWT, body weight; CI, confidence
interval; CV, coefficient of variation; d, diastolic; FAC, fractional area change; FS, fractional shortening; HR, heart rate; IVS, interventricular septal thickness; LA, left atrium or left atrial; LAA, left
atrial area; LAD, left atrial diameter; llx, left-parasternal long-axis view; LV, left ventricle or left ventricular; LVFW, left-ventricular free wall; LVID, left-ventricular internal diameter; lx, long axis;
M-mode, motion mode; MR, mitral regurgitation; MWT, mean wall thickness; NSR, normal sinus rhythm; RC, repeatability coefficient; RR, R-R interval in the ECG; RWT, relative wall thickness; s,
systolic; SD, standard deviation; sx, short axis; TR, tricuspid regurgitation; WB, Warmblood horse.
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multidimensional indices. Area-based or volumetric indices that reflect LV long-axis
motion should be included.
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1 | INTRODUCTION
Echocardiography is an indispensable diagnostic procedure in equine
cardiology.1,2 Two-dimensional (2D) gray-scale imaging and M-mode
echocardiography provide the basis for noninvasive evaluation of car-
diac structures, chamber dimensions, and chamber function. In partic-
ular, assessment of left-ventricular (LV) dimensions and function is a
crucial part of every echocardiographic examination and provides
important information on hemodynamics, LV remodeling, and severity
of disease. Traditionally, LV wall thickness and LV internal diameter
have been measured from a right-parasternal short-axis view at the
chordal level using M-mode recordings. However, standardized place-
ment of the M-mode cursor (ie, bisecting the LV at the chordal level,
parallel to the mitral annulus) can be challenging and is difficult to ver-
ify in all 3 dimensions.3-5 Such linear measurements of wall thickness
may not be accurate estimates of LV mass, particularly if asymmetric
thickening is present. Furthermore, these linear measurements of the
LV minor dimension may not well describe true LV size, as asymmetric
LV dilation and dimensional changes along the major axis of the ven-
tricle are neglected.4 Consequently, LV fractional shortening (FS), the
most commonly used index of LV systolic function in horses calcu-
lated from the LV internal dimensions measured at end-diastole and
peak-systole, only represents the relative shortening of the LV in 1
single dimension, disregarding the fact that the LV contracts in all
3 dimensions. It may lack accuracy when the LV does not contract
synchronously or when the cursor line is not placed optimally. A previ-
ous study indicated that LV FS, as opposed to other echocardio-
graphic indices, is not suitable to detect exercise-induced changes in
LV function in horses.6 Hence, reliance on this index as a single mea-
surement of LV systolic function may be problematic.
Measures that consider the short-axis area and the length of the
LV may be more accurate estimates of internal LV dimensions and LV
mass. Area-based measurements are less sensitive to asynchronous
wall motion and allow assessment of shortening in 2 dimensions. Vol-
umetric indices of cardiac size and function, considering all 3 dimen-
sions, can be calculated using a variety of geometrical models and are
generally considered more accurate and least affected by altered
chamber geometry,4 but differences and limitations related to the
geometrical model used need to be considered.4,5,7 This group rou-
tinely uses area-based indices and volumetric estimates of LV size and
function that have been reported in a variety of studies.6,8-10 How-
ever, at most institutions, area- and volume-based measurements of
LV systolic function are primarily used in research settings and they
are not widely established for routine use in horses.
The goals of this study were to investigate the feasibility and
measurement reliability of different echocardiographic modalities for
assessment of LV size and mechanical function, to calculate reference
intervals in a group of healthy horses, to provide “proof of concept”
for using volumetric estimates of LV size and function by comparing
dimensional measurements and functional indices between healthy
horses and horses with heart disease, and to compare the conven-
tional unidimensional indices of LV size and function to area-based
indices and to LV volume estimates that are based on a combination
of linear and area measurements of the LV. We hypothesized that LV
areas and volumetric estimates of LV size and function can be easily
measured, are sufficiently reliable, allow detection of LV enlargement
and dysfunction in horses with heart disease and provide complemen-
tary information to the conventional linear indices.
2 | MATERIALS AND METHODS
2.1 | Study sample
The study sample was chosen retrospectively from the digital echo-
cardiography database (GE EchoPAC, GE Healthcare, Glattbrugg,
Switzerland) of the Equine Hospital of the University of Zurich and
included horses that underwent an echocardiographic examination at
the hospital over a 4.5-year period. Enrollment criteria were:
Warmblood breed; age >2 years; presence of normal sinus rhythm;
absence of cardiovascular disease (healthy group) or presence of
mitral or aortic regurgitation as a primary diagnosis (diseased group);
and the availability of a complete, standardized echocardiogram of
adequate quality, with an ECG recorded simultaneously and per-
formed by a single operator (CCS) on a digital echocardiography sys-
tem (GE EchoPAC, GE Healthcare, Glattbrugg, Switzerland). Horses
that were sedated prior to or during the echocardiographic examina-
tion were excluded from the study.
One hundred Warmblood horses fulfilled the inclusion criteria.
Thirty horses were considered healthy based on medical history, phys-
ical examination, electrocardiography and transthoracic echocardiog-
raphy. They included 12 females and 18 males with a body weight of
450-680 (570 ± 53) kg and an age of 6-23 (12 ± 4) years [range
(mean ± SD)]. The remaining 70 horses had a primary diagnosis of MR
(n = 42; 16 females, 26 males; 430-710 (579 ± 65) kg; 4-28 (13 ± 5)
years) or AR (n = 28; 9 females, 19 males; 495-720 (582 ± 54) kg;
5-25 (17 ± 5) years); none of the horses was in congestive heart
failure.
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All animals had been examined within routine hospital procedures
and had received adequate human care according to the ethical stan-
dards of the university. This study being based on a retrospective data
analysis, a specific animal use protocol approved by the governmental
authorities was not required.
2.2 | Echocardiography
All horses had undergone a complete echocardiographic examination
according to a standardized protocol.1 During the examination, all
horses had been standing in a quiet room and restrained by an experi-
enced handler. Transthoracic 2D echocardiography (2DE) had been
performed using a high-end digital echocardiograph (GE Vivid 7 Ultra-
sound system, GE Healthcare, Glattbrugg, Switzerland) with a phased
array sector transducer (M4S phased array transducer, GE Healthcare,
Glattbrugg, Switzerland) working at frequencies of 1.7/3.6 MHz
(octave harmonics) and at frame rates between 46.8 and
77.9 frames/s (fps). An ECG had been recorded simultaneously for
timing purposes.
All recordings had been obtained in right-parasternal imaging
planes. The LV had been imaged in 2D mode in a short-axis view at
the chordal level and in a long-axis (4-chamber) view. For the latter
view, the probe had been directed slightly ventrally, so that the
entire ventricle, including the mitral valve annulus and the ventricu-
lar apex, was visible in its entirety throughout the cardiac cycle.1
The left atrium had been imaged in a separate long-axis (4-cham-
ber) view directed dorsally to image the left atrium in its entirety
throughout the cardiac cycle. The aortic valve and ascending aorta
had been imaged in a long-axis view of the left ventricular outflow
tract.
In each imaging plane, at least 3 representative, nonconsecutive
cardiac cycles had been recorded. All images had been stored as 2D
cine-loops in digital raw-data format (GE EchoPAC, GE Healthcare,
Glattbrugg, Switzerland).
2.3 | Measurements
All measurements were performed offline by a single observer (DJB)
using the digital raw-data image files (GE EchoPAC, GE Healthcare,
Glattbrugg, Switzerland). Three nonconsecutive, randomly chosen car-
diac cycles of adequate quality were measured for each imaging plane.
Cycles immediately following an incident of 2nd degree atrio-ventricu-
lar block were excluded from analyses. In horses, in which the avail-
able recordings did not contain a sufficient number of complete
cardiac cycles for all imaging planes, all available cycles were mea-
sured. On some recordings, insufficient image quality prevented
unambiguous identification of anatomical landmarks for measure-
ments on 3 nonconsecutive cycles; in those cases, only the cycles
were measured in which the landmarks could be clearly identified.
The HR of each measured cycle was calculated based on the RR inter-
val preceding the analyzed cycle (HR = 600000/RR).
The echocardiographic variables measured for the purpose of this
study are listed in Appendix S1. In summary, the following measure-
ments were performed1,3,4,6,7,11-13:
The peak-systolic aortic annular diameter (AAD) in a right-
parasternal long-axis left ventricular outflow tract view, as an internal
reference for body size; maximum left atrial (LA) dimensions in a right-
parasternal long-axis 4 chamber view, optimized to image the LA, for
calculation of LA-to-LV-dimensional ratios; linear measurements of LV
size and function in 2DE-derived anatomic M-mode (AAM) recordings
in a right-parasternal short-axis view at the chordal level; area mea-
surements of LV size and function in a right-parasternal long-axis
4-chamber view optimized to image the LV and in a right-parasternal
short-axis view at the chordal level, respectively; and volumetric esti-
mates of LV size and function in a right-parasternal long-axis 4 cham-
ber view optimized to image the LV, calculated using the modified
(single plane) Simpson's model of discs, the area-length model, and
the bullet model, respectively.
The LA dimensions, the LV internal chamber dimensions at end-
diastole, and cardiac output were corrected for differences in body
weight using the principles of allometric scaling.11,14-16 Specifically,
the measurements were normalized to a body weight (BWT) of
500 kg using the following equations: diameter (500) = measured
diameter/BWT1/3 × 5001/3; area (500) = measured area/BWT2/3
× 5002/3; volume (500) = calculated volume/BWT × 500. In addition,
linear indices were indexed to AAD, area measurements were indexed
to AAD2, and volumetric estimates were indexed to AAD3.
Grading of severity of valvular regurgitation (trace, trivial, mild,
moderate, severe) was achieved using a scoring system based on the
number of imaging planes in which the high-velocity jet could be
observed, the duration of the regurgitant signal, and the high-velocity
jet area relative to the receiving chamber.17 Thereby, regurgitation
was classified trivial when the regurgitant signal was visible in 1 or
more imaging planes, but was not present throughout systole and
diastole and, at its largest, occupied >1/8 to 1/4 of the 2D area of the
LA or LVOT, respectively, when assessed subjectively. Regurgitation
was classified more than trivial (ie, mild, moderate, or severe) when it
was easily located from multiple imaging planes and was present
throughout systole or diastole. A regurgitant signal was classified mild
when it occupied from 1/4 to 1/2 of the LA or LVOT; moderate when
it occupied >1/2 to 3/4 of the LA or LVOT; and severe when it occu-
pied >3/4 of the LA or LVOT, respectively. The horses were grouped
according to the primarily affected valve, as judged by the clinician
performing the echocardiogram (CCS).
2.4 | Data analysis and statistics
Data collection, graphical presentation, data analysis, and statistics
were performed using commercially available computer software.
To establish reference intervals for the measured and calculated
variables, we included the data of the 30 healthy horses. A dedicated
software package was used (Microsoft Excel, Microsoft Corporation,
Santa Rosa, CA; Reference Value Advisor v2.1, National Veterinary
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School, Toulouse, France). Distribution of the data was checked using
raw data box-and-whisker plots, histograms, and normal probability
plots. The lower and upper limits of the reference intervals were cal-
culated as mean ± t(n-1) × SD, with t(n-1) being the critical value of a t-
distribution with n-1 degrees of freedom and for a 95% prediction
interval and SD being the standard deviation. For normally distributed
variables, untransformed data were used. If normal distribution could
not be assumed, the reference interval was calculated based on Box-
Cox transformed data. If individual outliers were identified by the
software, they were generally retained in the analyses unless they
were clearly identified as aberrant observations (ie, single, clearly iso-
lated outliers originating from echocardiographic recordings of bor-
derline quality), in which case they were excluded from calculations.
The 90% confidence intervals (CI) of the limits of the reference inter-
vals were determined using a bootstrap method.
The relationship of echocardiographic variables obtained in
healthy Warmblood horses to BWT was assessed using linear regres-
sion analyses (GraphPad Prism v5.02 for Windows, GraphPad
Software, La Jolla, CA). Where available, both raw data and weight-
corrected data were included in linear regression analyses in order to
assess the effect of weight correction.
The echocardiographic data of the healthy horses were compared
to the data obtained on horses with a primary diagnosis of trivial-to-
mild MR and moderate-to-severe MR, and on horses with a primary
diagnosis of trivial-to-mild AR, moderate AR, and severe AR, respec-
tively, using 1-way analysis of variance (ANOVA) with Dunnett's post
hoc test (GraphPad Prism v5.02 for Windows, GraphPad Software, La
Jolla, CA). The groups of moderate MR and severe MR were pooled,
because the database contained only 1 horse with severe MR that ful-
filled all inclusion criteria. Homogeneity of variances was assessed by
graphical display of the data and validity of the normality assumption
was confirmed by assessment of normal probability plots of the resid-
uals. For each group, summary statistics (mean ± SD) were calculated.
To determine the intraobserver and interobserver measurement
variability, a subgroup of 10 randomly selected horses (5 healthy
horses and 5 horses with cardiac disease) was remeasured by the
same observer (DJB) and by a second observer (CCS) on different
days. Both observers were blinded to signalment, diagnosis, previously
measured cycles, and previous measurements. Measurement variabil-
ity was quantified using the within-subject variance for repeated mea-
surements (residual mean square) determined by 1-way ANOVA with
horses as the groups.18 The within-subject SD (sw) was calculated as
the square root of the residual mean square (SigmaPlot v12.5, Systat
Software, Inc., San Jose, CA). Variability was reported in 2 ways: The
within-subject coefficient of variation (CV) was calculated as CV = sw/
mean × 100 and expressed as a percent value. In addition to the CV,
the repeatability coefficient (RC, ie, the absolute value below which
the difference between 2 measurements will lie with 95% probability)
was estimated following the British Standards Institution recommen-
dations as follows: RC = 1.96 × √2 × sw = 2.77 × sw.
18 The RC was
reported to provide a clinically applicable measure of variability, hence
an absolute value that allows comparison with measured changes in
echocardiographic variables on a case-by-case basis. When applied
clinically, the magnitude of change observed in a variable that is mea-
sured on 2 different occasions can be put in relation to the RC, to
judge whether the change might be simply due to measurement error
(observed change ≤ RC) or whether the change might represent a true
change (observed change > RC). Summary statistics (mean ± SD) of all
variables were calculated based on the first measurements of each
horse (n = 10) and were reported for reference.
For comparison of different methods of measurement, a subset
of core measurements (ie, indices of LV size at end-diastole, relative
wall thickness, mean wall thickness, and fractional ejection phase indi-
ces) was chosen and analyzed. The relationship between different
indices of LV dimensions and systolic function was assessed using lin-
ear regression analyses (GraphPad Prism v5.02 for Windows, Gra-
phPad Software, La Jolla, CA). Bland-Altman analyses were performed
to calculate mean bias and 95% limits of agreement for variables rep-
resenting the same LV dimensional or functional index but being cal-
culated using different methods (GraphPad Prism v5.02 for Windows,
GraphPad Software, La Jolla, CA).19,20
The number of horses in which different methods of measure-
ment obtained during a single examination revealed discordant results
concerning LV dimensions and systolic function (ie, 1 variable indi-
cated normal LV size and another variable indicated LV enlargement)
was expressed as proportion and percentage for a variety of combina-
tions. Agreement of different indices for detection of reduced, normal,
and increased LV size (ie, classification agreement as judged based on
the calculated reference intervals) in all horses and in horses with val-
vular regurgitation, respectively, was quantified using weighted kappa
(κw) statistics (GraphPad, QuickCalcs, Online Calculator, www.
graphpad.com/quickcalcs, GraphPad Software, La Jolla, CA). Thereby,
κw > 0.75 indicated excellent agreement, κw ranging from 0.40 to 0.75
indicated fair to good agreement, κw ranging from 0 to 0.39 indicated
poor agreement and κw < 0 indicated worse agreement.
21
The level of significance for all statistical analyses was P ≤ .05.
3 | RESULTS
The summary statistics, reference intervals and relationship to BWT
of echocardiographic variables of LV size and function are shown in
Table 1. Linear regression analyses showed that HR, AAD, LADmax,
LAAmax, LVFWs, LVIAd, LVIVd S, CO S, CO AL, and CO B were signifi-
cantly positively related to BWT. After allometric scaling to a standard
BWT of 500 kg and to AAD, respectively, LADmax, LAAmax, LVIAd,
LVIVd S, CO S, CO AL, and CO B were not significantly related to
BWT anymore.
Table 2 shows the comparison of echocardiographic variables of
aortic dimension, LA size, and LV size and function in healthy horses
and horses with various degrees of MR and AR, respectively. The
AAD was not affected by MR but was significantly enlarged with
severe AR. Left atrial dimensions were significantly affected by
moderate-severe MR but not by AR. Most linear, area-based and volu-
metric indices of LV internal dimensions were increased with
moderate-severe MR and with moderate and severe AR, respectively.
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Both M-mode-based and 2D area-based RWT measurements were
decreased with moderate-severe MR and with severe AR. M-mode-
based MWT was unaffected by valvular regurgitation but 2D area-
based MWT was decreased with moderate-severe MR. M-mode-
based LV FS and 2D short-axis area-based LV FAC and LV EF B were
not significantly affected by valvular regurgitation, but 2D long-axis
TABLE 1 Summary statistics, reference intervals, and linear regression analysis of variables used for measurement of LV size and systolic
function in healthy Warmblood horses
Variable
Summary statistics Reference intervals
Linear regression
(body weight)
Unit n Mean Median SD
Lower limit of reference
interval (90% CI)
Upper limit of reference
interval (90% CI) R2 P value
Heart rate
HR bpm 28 40 39 6.2 27 (23.8-30.9) 53 (49.4-55.9) 0.34 .001a
Aortic dimensions
AAD cm 29 6.9 6.9 0.37 6.1 (5.96-6.33) 7.7 (7.47-7.87) 0.369 <.001a
Measurements of LA size
LADmax cm 29 12.7 12.6 0.66 11.4 (11.03-11.8) 14.1 (13.7-14.5) 0.224 .008
a
LADmax/AAD – 29 1.814 1.816 0.117 1.571 (1.506-1.637) 2.057 (1.99-2.121) 0.03 .36
LADmax (500) cm 28 12.2 12.2 0.49 11.1 (10.84-11.41) 13.2 (12.92-13.45) 0.005 .73
LAAmax cm
2 28 109.7 110.4 7.14 94.7 (91.01-99.15) 124.6 (120.65-128.54) 0.615 <.001a
LAAmax/AAD
2
– 29 2.299 2.299 0.221 1.839 (1.720-1.951) 2.76 (2.647-2.897) 0.009 .61
LAAmax (500) cm
2 30 100.5 100.8 5.52 89.0 (86.44-92.12) 112.0 (109.34-114.64) 0.017 .49
Linear measurements of LV size and function (M-mode, short axis at chordal level)
IVSd cm 30 3.0 2.9 0.26 2.4 (2.29-2.56) 3.5 (3.35-3.64) 0.005 .72
LVIDd cm 30 12.0 11.6 0.89 9.7 (9.26-10.2) 13.4 (12.87-13.88) 0.005 .7
LVIDd/AAD – 30 1.667 1.655 0.164 1.327 (1.241-1.412) 2.007 (1.914-2.103) 0.129 .05
LVIDd (500) cm 30 11.1 11 0.89 9.2 (8.78-9.7) 12.9 (12.46-13.45) 0.1 .09
LVFWd cm 30 2.6 2.5 0.39 1.8 (1.59-2.01) 3.4 (3.22-3.65) 0.06 .19
IVSs cm 30 4.5 4.5 0.42 3.6 (3.43-3.89) 5.4 (5.18-5.65) 0.006 .68
LVIDs cm 30 6.9 6.9 1.05 4.7 (4.16-5.34) 9.1 (8.58-9.63) 0.008 0.64
LVFWs cm 30 4.7 4.6 0.53 3.6 (3.27-3.89) 5.8 (5.48-6.03) 0.151 .03
a
LV FS % 30 40 39 6.4 27 (23.0-30.4) 54 (50.4-56.7) 0.035 .32
RWTd – 29 0.487 0.479 0.063 0.357 (0.322-0.389) 0.617 (0.582-0.651) 0.005 .72
MWTd cm 30 2.8 2.8 0.24 2.3 (2.16-2.42) 3.3 (3.15-3.43) 0.027 .38
LADmax/LVIDd – 30 1.102 1.1 0.088 0.919 (0.869-0.967) 1.284 (1.237-1.335) 0.081 .13
Area measurements of LV size and function (2D echocardiography, long axis)
LVIAd cm
2 29 183.7 180.6 15.33 151.8 (143.12-160.65) 215.7 (206.87-223.82) 0.141 .04a
LVIAd/AAD
2
– 30 3.861 3.822 0.487 2.848 (2.604-3.114) 4.873 (4.596-5.127) 0.106 .08
LVIAd (500) cm
2 29 168.8 168.5 12.99 141.7 (135.03-149.29) 195.8 (188.61-203.34) 0.068 .17
LVIAs cm
2 29 81.4 80.1 11.60 57.2 (51.17-63.84) 105.6 (99.71-112.47) 0.064 .18
LV FAC % 30 55 55 5.0 45 (42.8-47.9) 66 (63.2-68.0) 0 .99
LAAmax/LVIAd – 30 0.594 0.599 0.060 0.468 (0.436-0.501) 0.719 (0.685-0.753) 0.106 .08
Area measurements of LV size and function (2D echocardiography, short axis)
LVIsxAd cm
2 28 94.6 97.1 11.83 69.9 (119.30-76.79) 119.3 (112.05-126.08) 0.041 .28
LVIsxAd/AAD
2
– 29 1.995 1.949 0.35 1.266 (1.068-1.462) 2.725 (2.513-2.917) 0.077 .14
LVIsxAd (500) cm
2 30 89.4 89.9 13.89 60.5 (53.16-67.98) 118.3 (110.24-125.91) 0.035 .32
LVIsxAs cm
2 29 32 31.2 8.38 14.5 (10.36-19.38) 49.4 (45.04-53.92) 0.005 .73
LVsx FAC % 30 67 66 5.9 54 (51.4-57.7) 79 (76.1-82.1) 0.005 .7
RWTd Asx – 30 0.495 0.486 0.063 0.365 (0.332-0.400) 0.625 (0.588-0.660) 0.001 .88
MWTd Asx cm 30 2.7 2.7 0.21 2.3 (2.15-2.41) 3.2 (3.05-3.26) 0.058 .2
(Continues)
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area-based LV FAC, LV EF S and LV EF AL were significantly
decreased with trivial-mild and moderate-severe MR and with trivial-
mild AR. All stroke volume indices were significantly increased with
moderate and severe AR, whereas cardiac output indices were only
increased with severe AR.
The intraobserver and interobserver measurement variability of
all variables is summarized in Table 3. The coefficient of variation was
<15% for all echocardiographic indices, except for the intraobserver
variability of LVIVd B/AAD
3 (CV = 16.2%). Fifty-four of 59 indices had
an intraobserver CV < 10%; all 5 indices with a CV ≥10% (range,
10.3%-16.2%) were indices that were allometrically scaled to AAD.
Forty-six of 59 indices had an interobserver CV < 10%; of the 13 indi-
ces with a CV ≥10%, 7 were indices calculated using the modified
Simpson's model of discs (range, 10.0%-12.9%) and 3 were indices cal-
culated using the area-length model (range, 10.0%-13.5%). The aver-
age of the intraobserver and interobserver variability was lower for
linear variables (2.5% and 3.0%) compared to area-based variables
(4.7%, 5.8% and 5.7%, 4.6%) and volumetric variables (5.3%-8.2% and
6.4%-9.3%) (Supporting Information Table S1).
Supporting Information Figures S1-S5 summarize the agreement
of different echocardiographic variables used for assessment of LV
size, LV wall thickness, and LV systolic function. Table 4 shows the
proportions and percentages of horses in which different methods of
measurement obtained during a single echocardiographic examination
revealed discordant results concerning LV size, LV wall thickness, and
LV systolic function. Classification agreement, quantified by weighted
TABLE 1 (Continued)
Variable
Summary statistics Reference intervals
Linear regression
(body weight)
Unit n Mean Median SD
Lower limit of reference
interval (90% CI)
Upper limit of reference
interval (90% CI) R2 P value
Volumetric estimates of LV size and function (2D echocardiography)
Modified (single plane) Simpson's (S) model of discs




– 30 4.504 4.394 0.891 2.651 (2.177-3.160) 6.357 (5.870-6.848) 0.091 .1
LVIVd S (500) mL 29 1296 1290 164.1 954 (862.9-1045.7) 1638 (1537.4-1710.5) 0.055 .21
LVIVs S mL 28 412 415 81.6 241 (200.5-291.4) 582 (540.4-624.9) 0.068 .17
LV EF S % 30 71 70 4.9 61 (59.1-63.6) 81 (79.1-82.8) 0 .96
SV S mL 28 1065 1042 139.2 774 (702.1-854.8) 1356 (1277.7-1434.1) 0.112 .07
CO S L/min 25 41.8 43.3 7.91 25.1 (19.83-29.82) 58.4 (53.39-63.02) 0.313 .002a
CO S (500) L/min 25 37.1 37.0 6.02 24.4 (20.93-28.35) 49.7 (46.13-53.06) 0.003 .81
Area length (AL) model
LVIVd AL mL 29 1542 1504 216.2 1091 (967.7-1211.1) 1992 (1871.0-2099.6) 0.116 .07
LVIVd AL/AAD
3
– 29 4.625 4.518 0.843 2.869 (2.428-3.350) 6.381 (5.901-6.821) 0.096 .1
LVIVd AL (500) mL 29 1356 1365 177.3 987 (891.3-1080.5) 1726 (1620.6-1827.4) 0.058 .2
LVIVs AL mL 29 424 423 102.5 210 (152.5-264.2) 637 (583.4-692.0) 0.049 .24
LV EF AL % 30 72 72 5 62 (59.2-64.0) 83 (79.9-85.4) 0 .99
SV AL mL 28 1132 1108 154.6 809 (722.1-900.9) 1454 (1361.7-1533.2) 0.109 .08
CO AL L/min 25 44.6 45.5 8.03 27.6 (22.84-33.03) 61.5 (56.37-65.86) 0.308 .002a
CO AL (500) L/min 25 39.5 39.2 6.05 26.8 (23.31-30.76) 52.3 (48.64-55.60) 0.001 .91
Bullet (B) model
LVIVd B mL 28 1466 1492 189.9 1069 (959.4-1175.9) 1862 (1756.8-1975.4) 0.073 .19
LVIVd B/AAD
3
– 30 4.600 4.479 1.091 2.794 (2.500-3.155) 7.274 (6.386-8.272) 0.094 .1
LVIVd B (500) mL 29 1316 1326 203.0 893 (779.6-1002.6) 1739 (1620.4-1847.6) 0.043 .3
LVIVs B mL 28 349 346 89.0 163 (112.1-213.5) 534 (481.8-583.0) 0.019 .47
LV EF B % 30 76 76 4.8 66 (63.1-68.4) 86 (83.3-88.1) 0.002 .8
SV B mL 28 1117 1119 147.8 808 (726.9-898.9) 1426 (1339.7-1506.5) 0.099 .09
CO B L/min 27 44.8 43.6 8.42 27.1 (22.21-32.13) 62.4 (57.36-67.03) 0.446 <.001a
CO B (500) L/min 27 40.0 39.6 6.80 25.8 (22.05-30.06) 54.3 (50.36-57.85) <0.001 .96
aSignificant positive relationship to BWT. For detailed explanation of echocardiographic indices see Appendix S1.
Abbreviations: CI, confidence interval; n, number of horses; SD, standard deviation.
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Kappa, was largely independent of the study sample under investiga-
tion (ie, all horses vs. horses with valvular regurgitation only). Agree-
ment was fair to excellent for all indices of LV internal dimensions at
end-diastole and for MWT but was poor for RWT. Agreement of
area- and volume-based ejection phase indices of LV systolic function
(ie, FAC, EF) with LV FS was poor or worse and with LVsx FAC it was
mostly poor. Agreement of EF indices with LV FAC was fair to
excellent.
4 | DISCUSSION
This study defines reference intervals and describes measurement
variability for a multitude of uni-, 2-, and 3-dimensional echocardio-
graphic indices of LV size and function in Warmblood horses. It fur-
ther provides proof of concept for the use of area-based variables and
2DE-based volumetric estimates of LV size and function in horses.
Table 1 summarizes reference intervals for a comprehensive set
of variables of LV size and function. Other studies in horses demon-
strated that LA and LV dimensions are significantly related to
BWT,14-16,22-26 but detailed comparisons of these studies are difficult
because of differences in study samples in regard to breed, age range,
and range of body weight. In one study, aortic root diameter, LVIDd,
LVIDs, and LVFWs were significantly related to BWT in adult
Standardbreds,23 whereas in another study little or no linear correla-
tion was found between any of the linear LV dimensions and BWT
within a group of large horses of different breeds.26 To our knowl-
edge, the relationship of LV areas and volumes to BWT, taking LV
long-axis dimensions into consideration, has not been previously
investigated in horses. In this study, a significant, weak to moderate
influence of BWT was demonstrated for AAD and for maximum LA
dimensions (which were reported for comparison). A significant but
very weak effect of BWT was shown for diastolic LV dimensions that
were derived from long-axis measurements (ie, LVIAd, LVIVd S), but
not for those that were derived from short-axis measurements (ie,
LVIDd, LVIsxAd, LVIVd B). This suggests that body size influences car-
diac long-axis dimensions to a larger extent than short-axis dimen-
sions. A significant influence of BWT was not shown for peak-systolic
LV dimensions, fractional changes of LV internal dimensions, and mea-
surements of LV wall thickness (with the exception of LVFWs). This
can be explained by a lack of power to detect relatively small weight-
related alterations within the study sample, but also suggests that
weight-related differences may not be clinically relevant for these var-
iables. Cardiac output was significantly but weakly influenced by
BWT; as CO = SV × HR and since SV was not significantly related to
BWT, HR appeared to be the major determinant of higher cardiac out-
put with higher body weight. This was somewhat unexpected, since
HR was previously shown to be inversely related to body mass in
horses and ponies of different breeds, ranging from 46 to 1018 kg.27
However, the present study sample only comprised Warmblood
horses with a relatively narrow range of body weights (450-680 kg).
Part of the differences in body weight might in fact have been related
to differences in body condition as opposed to true differences in
body size, which could explain the positive correlation of HR to body
weight.28,29 This is purely hypothetical however, because body condi-
tion was not assessed in this study sample.
Consequently to these findings, for further comparisons, all dia-
stolic LV dimensions and CO were allometrically scaled to correct for
differences in BWT, based on the assumption that cardiac volumes
are linearly related to BWT, cross-sectional areas are linearly related
to BWT2/3 (proportional to body surface area), and linear dimensions
are linearly related to BWT1/3 (proportional to body length).14,15,30,31
Similar to previous studies, a scaling approach was chosen that cor-
rects echocardiographic variables to a standard body weight of
500 kg and allows intuitive interpretation of weight-corrected vari-
ables.8,9,16 In addition, a second method was applied to correct for dif-
ferent body size by indexing LV dimensions to AAD, under the
assumption that aortic annular dimensions are directly related to BWT
(which was confirmed by the results of this study), are little affected
by alterations in stroke volume and blood pressure, and can therefore
serve as an internal reference for body size in lack of an accurate body
weight.11,14,16,30
Overall, the results of this study showed that allometric scaling of
echocardiographic measurements of diastolic LV dimensions and CO
in Warmblood horses is effective and eliminates the significant influ-
ence of BWT on these variables (Table 2). Hence, normalization of
measurements of diastolic LV size and CO to a BWT of 500 kg pro-
vides a clinically applicable and intuitive method for weight correction
in Warmblood horses. As indicated by the data, indexing diastolic LV
dimensions to AAD might not be as sensitive to detect LV enlarge-
ment as scaling to a standard BWT.
Noticeably, even the diastolic LV dimensions that were not
related to BWT remained unaffected by BWT after allometric scaling.
Therefore, for consistency, further comparisons were conducted using
the native and the allometrically scaled data for all diastolic LV
variables.
It is important to notice that in the absence of respective data,
allometric scaling must not be applied to correct for differences in
BWT across different equine breeds. Another limitation to consider is
the potential impact of body condition on the BWT-based scaling
approach. Theoretically, the use of the ideal body weight as opposed
to the actual body weight might result in better correction for differ-
ences in BWT. However, the ideal body weight can only be estimated
by approximation, which would be an additional source of error.
Finally, indexing of echocardiographic variables to AAD might not be
valid for horses with aortic valve disease, because dilatation of the
aortic root is expected in horses with moderate to severe aortic
regurgitation.16,32
Progressive mitral and aortic regurgitation are associated with LA
and LV volume overload, with the degree of chamber enlargement
depending on the severity of valvular regurgitation.32-35 Therefore, in
the absence of a gold standard for quantification of LV size and func-
tion, comparison of echocardiographic variables between healthy
horses and horses with different severities of valvular regurgitation
allows assessment of the variables' relative clinical value to detect
disease-related alterations. The results of this study provide proof of
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Mitral regurgitation (mean ± SD)
(P value post hoc test)
Aortic regurgitation (mean ± SD)




(ANOVA) Trivial-mild Moderate Severe
n – 30 22 20 8 9 11
Age y 12 ± 4 13 ± 5 12 ± 6 14 ± 5 16 ± 6 20 ± 4
BWT kg 570 ± 53 589 ± 74 569 ± 55 590 ± 40 584 ± 70 573 ± 20
HR bpm 42 ± 8 43 ± 14 40 ± 7 40 ± 5 38 ± 6 41 ± 5
Aortic dimensions






Measurements of LA size




.065 13.0 ± 0.86 13.5 ± 0.58 13.3 ± 1.40




.3 1.902 ± 0.092 1.804 ± 0.104 1.799 ± 0.118




.05 12.3 ± 0.73 12.8 ± 0.48 12.7 ± 1.14
LAAmax cm




.23 107.8 ± 11.66 117.1 ± 11.41 116.2 ± 20.40
LAAmax/AAD
2




.14 2.303 ± 0.186 2.109 ± 0.283 2.119 ± 0.270
LAAmax (500) cm




.09 96.5 ± 8.58 105.8 ± 9.03 106.1 ± 17.28
Linear measurements of LV size and function (M-mode, short axis at chordal level)
IVSd cm 3.0 ± 0.26 .26 2.9 ± 0.33 2.8 ± 0.42 .84 3.0 ± 0.29 3.1 ± 0.49 3.0 ± 0.45






























LVFWd cm 2.6 ± 0.39 .33 2.5 ± 0.36 2.7 ± 0.41 .31 2.5 ± 0.23 2.8 ± 0.35 2.7 ± 0.46
IVSs cm 4.5 ± 0.43 .4 4.4 ± 0.49 4.4 ± 0.43 .26 4.8 ± 0.46 4.8 ± 0.40 4.8 ± 0.82






































Mitral regurgitation (mean ± SD)
(P value post hoc test)
Aortic regurgitation (mean ± SD)




(ANOVA) Trivial-mild Moderate Severe
LV FS % 40 ± 6.4 .78 40 ± 6.7 39 ± 6.5 .76 42 ± 5.4 42 ± 6.9 39 ± 7.0










MWTd cm 2.8 ± 0.24 .45 2.7 ± 0.30 2.7 ± 0.32 .45 2.8 ± 0.26 2.9 ± 0.34 2.9 ± 0.38






Area measurements of LV size and function (2D echocardiography, long axis)
LVIAd cm








– 3.861 ± 0.487 .14 3.726 ± 0.645 4.071 ± 0.452 .06 4.268 ± 0.523 3.836 ± 0.552 4.296 ± 0.628
LVIAd (500) cm





















.06 50 ± 5.9 55 ± 3.4 55 ± 5.9










Area measurements of LV size and function (2D echocardiography, short axis)
LVIsxAd cm












































LVsx FAC % 67 ± 5.9 .28 64 ± 7.2 64 ± 7.9 .43 66 ± 3.5 66 ± 5.1 63 ± 8.6












































Mitral regurgitation (mean ± SD)
(P value post hoc test)
Aortic regurgitation (mean ± SD)




(ANOVA) Trivial-mild Moderate Severe
Volumetric estimates of LV size and function (2D echocardiography)
Modified (single plane) Simpson's (S) model of discs






































































Area length (AL) model


































































































Mitral regurgitation (mean ± SD)
(P value post hoc test)
Aortic regurgitation (mean ± SD)




(ANOVA) Trivial-mild Moderate Severe
Bullet (B) model










































LV EF B % 76 ± 4.8 .12 74 ± 5.6 73 ± 6.9 .6 74 ± 3.1 75 ± 4.4 74 ± 6.3


















Note: Significant differences between groups are marked in bold. For detailed explanation of echocardiographic indices see Appendix S1.

























TABLE 3 Intraobserver and interobserver measurement variability of variables used for measurements of LV size and function
Intraobserver variability Interobserver variability
Variables Unit Mean ± SD CV (%) RC Mean ± SD CV (%) RC
Heart rate
HR bpm 46 ± 8.6 0.8 1 46 ± 8.6 1.1 1
Aortic dimensions
AAD cm 7.0 ± 0.84 3.3 0.6 6.8 ± 0.81 3.7 0.7
Measurements of LA size
LADmax cm 12.6 ± 1.21 2.1 0.7 12.4 ± 1.23 3.1 1.1
LADmax/AAD – 1.827 ± 0.162 5.0 0.252 1.831 ± 0.160 4.7 0.237
LADmax (500) cm 12.1 ± 0.69 2.1 0.7 11.9 ± 0.78 3.0 1.0
LAAmax cm
2 108.1 ± 18.12 3.0 9.0 104.2 ± 18.85 7.7 22.1
LAAmax/AAD
2
– 2.289 ± 0.441 10.8 0.684 2.268 ± 0.408 8.4 0.530
LAAmax (500) cm
2 98.7 ± 8.46 2.8 7.8 95.1 ± 9.80 7.3 19.1
Linear measurements of LV size and function (M-mode, short axis at chordal level)
IVSd cm 3.0 ± 0.41 4.7 0.4 3.1 ± 0.40 6.2 0.5
LVIDd cm 11.9 ± 2.29 0.9 0.3 11.9 ± 2.30 2.0 0.7
LVIDd/AAD – 1.794 ± 0.549 5.5 0.274 1.741 ± 0.240 5.7 0.274
LVIDd (500) cm 11.3 ± 1.83 0.8 0.2 11.4 ± 1.86 2.0 0.6
LVFWd cm 2.6 ± 0.40 5.9 0.4 2.6 ± 0.42 4.7 0.3
IVSs cm 4.4 ± 0.62 3.6 0.4 4.4 ± 0.64 3.2 0.4
LVIDs cm 7.1 ± 1.51 2.2 0.4 7.1 ± 1.43 1.9 0.4
LVFWs cm 4.6 ± 0.76 2.3 0.3 4.5 ± 0.75 2.4 0.3
LV FS % 40 ± 7.4 3.2 4 40 ± 6.9 3.3 4
RWTd – 0.485 ± 0.075 4.1 0.055 0.494 ± 0.088 4.9 0.067
MWTd cm 2.8 ± 0.35 3.9 0.3 2.9 ± 0.37 4.4 0.4
LADmax/LVIDd – 1.082 ± 0.145 2.2 0.067 1.066 ± 0.142 3.5 0.102
Area measurements of LV size and function (2D echocardiography, long axis)
LVIAd cm
2 189.4 ± 44.92 2.8 14.8 183.4 ± 44.51 6.3 32.1
LVIAd/AAD
2
– 3.960 ± 0.744 7.9 0.864 3.942 ± 0.643 5.6 0.612
LVIAd (500) cm
2 171.1 ± 27.55 5.3 25.3 165.7 ± 27.50 6.3 29.0
LVIAs cm
2 88.7 ± 27.43 5.0 12.3 87.0 ± 28.32 7.3 17.7
LV FAC % 54 ± 6.6 2.6 4 53 ± 6.7 2.8 4
LAAmax/LVIAd – 0.585 ± 0.096 4.2 0.068 0.583 ± 0.102 3.4 0.055
Area measurements of LV size and function (2D echocardiography, short axis)
LVIsxAd cm
2 102.0 ± 35.75 5.5 15.4 101.6 ± 37.18 3.6 10.0
LVIsxAd/AAD
2
– 2.112 ± 0.567 10.3 0.605 2.156 ± 0.547 9.3 0.553
LVIsxAd (500) cm
2 92.6 ± 26.65 5.6 14.5 92.0 ± 27.47 3.6 9.2
LVIsxAs cm
2 35.4 ± 14.83 4.5 4.5 36.3 ± 15.68 3.1 3.1
LVsx FAC % 65 ± 8.60 3.3 6 64 ± 9.3 3.6 6
MWTd Asx cm 2.7 ± 0.30 4.1 0.3 3.0 ± 0.37 10.2 0.8
RWTd Asx – 0.495 ± 0.082 4.9 0.068 0.544 ± 0.093 10.6 0.160
Volumetric estimates of LV size and function (2D echocardiography)
Modified (single plane) Simpson's (S) model of discs
LVIVd S mL 1632 ± 666.0 4.1 186 1542 ± 644.6 10.2 434
LVIVd S/AAD
3
– 4.808 ± 1.339 11.8 1.574 4.737 ± 1.175 8.5 1.118
LVIVd S (500) mL 1400 ± 432.0 4.7 183 1325 ± 423.2 10.4 381
LVIVs S mL 504 ± 256.1 7.8 109 483 ± 251.9 12.9 173
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concept that echocardiographic indices of LV size, to different
extents, can identify significant LV enlargement in horses with moder-
ate and severe mitral and aortic regurgitation, respectively (Table 2).
Independent of the geometric model used, SV was significantly
altered by moderate and severe AR and CO was significantly altered
by severe AR, but neither SV nor CO was significantly altered by MR,
likely to be explained by the lesser degree of LV volume overload (ie,
preload, represented by end-diastolic LV dimensions) seen in the
group of horses with MR compared to horses with AR in this study.
The ejection phase indices that are primarily based on LV short-axis
measurements (ie, LV FS, LVsx FAC, and LV EF B) were not able to
detect differences between healthy horses and horses with valvular
disease. Conversely, those that are primarily based on LV long-axis
measurements (ie, LV FAC, LV EF S, and LV EF AL) allowed to detect
disease-related differences. This suggests, in agreement with recom-
mendations published in the human literature,36-41 that long-axis
motion of the myocardium is critical in health and disease and should
be considered when assessing cardiac mechanical function in horses.
Overall, these findings support the complementary use of area-
based long-axis measurements of LV size and function and respective
volumetric estimates, in addition to the traditional linear short-axis
measurements in Warmblood horses with cardiac disease. Table 4 and
Supporting Information Figures S2 and S5 show that the single-plane
Simpson's model and the area-length model provide very similar esti-
mates of LV size and function, which can be explained by the fact that
these models are both based on an LV long-axis tracing (see Appendix
S1), whereas the bullet model also includes a measurement of the LV
short-axis area and therefore results in slightly different measure-
ments. The authors routinely use the single-plane Simpson's model of
discs to calculate volumetric estimates of LV size and function. How-
ever, the results of this study do not justify preferring 1 volumetric
model over another. A previous study on volumetric echocardiogra-
phy methods for cardiac output measurement in healthy adult horses
reported that Simpson's, area-length, and bullet models all provided
better agreement with lithium dilution than other methods (including
Teichholz and Cubic methods based on linear M-mode measurements
and Doppler interrogation of blood flow in the left-ventricular outflow
tract), but also was not able to identify clear advantages of 1 model
over another.13
Critical appraisal of the measurement variability (Table 3 and
Supporting Information Table S1) indicates an overall low variability
for all variables of LV size and function that were under investigation.
Indexing variables of end-diastolic LV dimensions to AAD introduced
additional measurement variability, again suggesting that this may not
TABLE 3 (Continued)
Intraobserver variability Interobserver variability
Variables Unit Mean ± SD CV (%) RC Mean ± SD CV (%) RC
LV EF S % 70 ± 6.6 1.9 4 70 ± 6.4 2.0 4
SV S mL 1128 ± 454.1 3.9 122 1059 ± 434.9 10.0 293
CO S L/min 49.3 ± 16.63 3.6 4.9 46.4 ± 15.88 10.0 12.9
CO S (500) L/min 42.3 ± 10.17 4.2 4.9 39.8 ± 9.73 10.1 11.1
Area length (AL) model
LVIVd AL mL 1710 ± 725.8 4.5 215 1627 ± 708.5 10.0 450
LVIVd AL/AAD
3
– 5.036 ± 1.478 12.3 1.719 4.981 ± 1.295 8.6 1.188
LVIVd AL (500) mL 1467 ± 475.5 5.0 202 1396 ± 469.9 10.3 397
LVIVs AL mL 516 ± 276.3 8.0 114 495 ± 278.7 13.5 186
LV EF AL % 71 ± 6.6 1.8 3 495 ± 278.7 2.0 4
SV AL mL 1194 ± 495.1 4.5 148 1131 ± 474.5 9.3 291
CO AL L/min 52.1 ± 17.67 4.1 6.0 49.4 ± 17.00 9.3 12.7
CO AL (500) L/min 44.6 ± 10.67 4.4 5.4 42.4 ± 10.34 9.4 11.0
Bullet (B) model
LVIVd B mL 1590 ± 682.6 6.3 279 1563 ± 689.0 5.1 220
LVIVd B/AAD
3
– 4.792 ± 1.752 16.2 2.146 4.863 ± 1.513 11.7 1.579
LVIVd B (500) mL 1373 ± 473.7 6.6 252 1347 ± 468.1 5.0 188
LVIVs B mL 413 ± 208.5 7.5 85 427 ± 222.6 3.1 37
LV EF B % 74 ± 7.9 2.7 6 73 ± 8.5 2.5 5
SV B mL 1176 ± 526.1 8.1 264 1137 ± 516.9 7.3 230
CO B L/min 53.7 ± 21.75 9.0 13.3 52.0 ± 22.06 8.2 11.8
CO B (500) L/min 45.6 ± 13.70 9.0 11.4 44.0 ± 13.63 7.9 9.6
Note: For detailed explanation of echocardiographic indices see Appendix S1.
Abbreviations: CV, coefficient of variation; RC, repeatability coefficient; SD, standard deviation.
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TABLE 4 Proportion (%) of horses in which different methods of measurement obtained during a single examination revealed discordant
results concerning left ventricular dimensions and systolic function
Variables indicate normal LV
dimensions and systolic function
Variables indicate LV dimensions and















LVIDd (500) LVIAd (500) 8/79 10.1% 0.602 7/49 14.3% 0.59
LVIsxAd (500) 3/80 3.8% 0.719 2/50 4.0% 0.725
LVIVd S (500) 8/79 10.1% 0.669 7/49 14.3% 0.659
LVIVd AL (500) 7/79 8.9% 0.656 6/49 12.2% 0.647
LVIVd B (500) 6/79 7.6% 0.716 4/49 8.2% 0.744
LVIAd (500) LVIDd (500) 5/76 6.6% 0.602 5/47 10.6% 0.59
LVIsxAd (500) 3/76 3.9% 0.661 3/47 6.4% 0.614
LVIVd S (500) 5/76 6.6% 0.784 5/47 10.6% 0.752
LVIVd AL (500) 4/76 5.3% 0.777 4/47 8.5% 0.745
LVIVd B (500) 5/76 6.6% 0.718 4/47 8.5% 0.704
LVIsxAd (500) LVIDd (500) 5/82 6.1% 0.719 5/53 9.4% 0.725
LVIAd (500) 8/81 9.9% 0.661 8/52 15.4% 0.614
LVIVd S (500) 8/81 9.9% 0.727 8/52 15.4% 0.686
LVIVd AL (500) 8/81 9.9% 0.653 8/52 15.4% 0.601
LVIVd B (500) 6/81 7.4% 0.777 5/52 9.6% 0.774
LVIVd S (500) LVIDd (500) 3/74 4.1% 0.669 3/45 6.7% 0.659
LVIAd (500) 3/74 4.1% 0.784 3/45 6.7% 0.752
LVIsxAd (500) 1/74 1.4% 0.727 1/45 2.2% 0.686
LVIVd AL (500) 0/74 0.0% 0.945 0/45 0.0% 0.936
LVIVd B (500) 5/74 6.8% 0.664 4/45 8.9% 0.634
LVIVd AL (500) LVIDd (500) 4/76 5.3% 0.656 4/47 8.5% 0.647
LVIAd (500) 4/76 5.3% 0.777 4/47 8.5% 0.745
LVIsxAd (500) 3/76 3.9% 0.653 3/47 6.4% 0.601
LVIVd S (500) 2/76 2.6% 0.945 2/47 4.3% 0.936
LVIVd B (500) 7/76 9.2% 0.595 6/47 12.8% 0.555
LVIVd B (500) LVIDd (500) 3/76 3.9% 0.716 3/48 6.3% 0.744
LVIAd (500) 5/76 6.6% 0.718 5/48 10.4% 0.704
LVIsxAd (500) 1/76 1.3% 0.777 1/48 2.1% 0.774
LVIVd S (500) 7/76 9.2% 0.664 7/48 14.6% 0.634
LVIVd AL (500) 7/76 9.2% 0.595 7/48 14.6% 0.555
RWTd RWTd Asx 8/92 8.7% 0.363 7/62 11.3% 0.369
RWTd Asx RWTd 4/88 4.5% 0.363 4/59 6.8% 0.369
MWTd MWTd Asx 6/90 6.7% 0.476 6/60 10.0% 0.464
MWTd Asx MWTd 4/88 4.5% 0.476 4/58 6.9% 0.464
LV FS LV FAC 9/95 9.5% −0.03 9/67 13.4% −0.024
LVsx FAC 4/96 4.2% 0.233 4/68 5.9% 0.32
LV EF S 8/95 8.4% −0.029 8/67 11.9% −0.023
LV EF AL 10/95 10.5% −0.031 10/67 14.9% −0.025
LV EF B 6/95 6.3% 0.178 6/67 9.0% 0.233
LV FAC LV FS 3/89 3.4% −0.03 1/59 1.7% −0.024
LVsx FAC 2/88 2.3% 0.279 2/58 3.4% 0.266
LV EF S 0/89 0.0% 0.937 0/59 0.0% 0.935
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be the preferred method for allometric scaling of variables (also see
above). Both intraobserver and interobserver measurement variabil-
ities were lowest for linear variables compared to area-based variables
and volumetric estimates of LV size and function, respectively. This
can be explained by the additional dimensions influencing measure-
ments and geometric estimates reported. Nonetheless, all CV were
judged to be sufficiently low for the respective variables to be used in
clinical routine. In any case, alterations in variables of LV size and
function would need to be sufficiently large (ie, larger than the respec-
tive RC) to be reliably detected in individual horses. Because of the
retrospective study design, this study only investigated the measure-
ment variability based on a single dataset measured repeatedly,
mostly influenced by operator-related and algorithm-related factors.
The day-to-day biological variability that would also affect the vari-
ables in a clinical setting over time will have to be quantified in future
studies.
With the lack of a gold standard, this study does not allow
quantifying accuracy of the respective variables or proving the
superiority of area-based measurements and volumetric estimates
of LV size over unidimensional variables. However, the results indi-
cate that agreement of different indices for detection of abnormal
end-diastolic LV dimensions was fair to excellent for all variables
(Table 4 and Supporting Information Figures S1 and S2). There was
fair to good agreement between MWTd and MWTd Asx but poor
agreement between RWTd and RWTd Asx (Table 4 and Supporting
Information Figure S3). Most strikingly, agreement between LV FS
and all other ejection phase indices was poor or worse and agree-
ment between LVsx FAC and LV FAC, LV EF S and LV EF AL,
respectively, was poor (Table 4 and Supporting Information -
Figure S4 and S5). This again supports the contention that variables
describing the short-axis motion of the LV do not adequately
reflect long-axis motion nor describe overall LV mechanical func-
tion.36-41 Excellent agreement was seen between LV EF S and LV
EF AL, respectively, and LV FAC, and between LV EF S and LV EF
AL, most likely representing the fact that these variables are all
mathematically related. Fair to good agreement was seen between
LV EF B and all other area-based and volumetric ejection phase
indices.
TABLE 4 (Continued)
Variables indicate normal LV
dimensions and systolic function
Variables indicate LV dimensions and















LV EF AL 1/89 1.1% 0.943 1/59 1.7% 0.941
LV EF B 2/89 2.2% 0.6 2/59 3.4% 0.588
LVsx FAC LV FS 2/94 2.1% 0.233 0/64 0.0% 0.32
LV FAC 7/93 7.5% 0.279 7/63 11.1% 0.266
LV EF S 6/93 6.5% 0.307 6/63 9.5% 0.295
LV EF AL 8/93 8.6% 0.255 8/63 12.7% 0.24
LV EF B 3/93 3.2% 0.717 3/63 4.8% 0.712
LV EF S LV FS 3/90 3.3% −0.029 1/60 1.7% −0.023
LV FAC 1/90 1.1% 0.937 1/60 1.7% 0.935
LVsx FAC 2/89 2.2% 0.307 2/59 3.4% 0.295
LV EF AL 2/90 2.2% 0.88 2/60 3.3% 0.876
LV EF B 3/90 3.3% 0.504 3/60 5.0% 0.49
LV EF AL LV FS 3/88 3.4% −0.031 1/58 1.7% −0.025
LV FAC 0/88 0.0% 0.943 0/58 0.0% 0.941
LVsx FAC 2/87 2.3% 0.255 2/57 3.5% 0.24
LV EF S 0/88 0.0% 0.88 0/58 0.0% 0.876
LV EF B 2/88 2.3% 0.559 2/58 3.4% 0.545
LV EF B LV FS 2/91 2.2% 0.178 0/61 0.0% 0.233
LV FAC 4/91 4.4% 0.6 4/61 6.6% 0.588
LVsx FAC 0/90 0.0% 0.717 0/60 0.0% 0.712
LV EF S 4/91 4.4% 0.504 4/61 6.6% 0.49
LV EF AL 5/91 5.5% 0.559 5/61 8.2% 0.545
Note: Weighted Kappa (κw) quantifies the method agreement: >0.75 = excellent (shaded in green), 0.4-0.75 = fair to good (shaded in yellow), 0-0.39 = poor
(shaded in orange), <0 = worse (shaded in red). For detailed explanation of echocardiographic indices see Appendix S1.
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However, even for variables with fair to excellent agreement, the
use of different variables may lead to discordant conclusions with
regard to the presence of LV enlargement or systolic dysfunction in
individual horses (Table 4 and Supporting Information Figures S1-S5).
This can likely be explained by inherent measurement variability and
by the fact that variables represent different uniplanar or biplanar
dimensions of an asymmetrical 3-dimensional structure that can
enlarge in a multidirectional fashion.16,42 Although on a theoretical
basis the use of area-based and volumetric variables might be prefera-
ble, the results of this study do not unconditionally support this
assumption. The results however strongly suggest that in addition to
subjective assessment of LV size and function, a variety of different
variables, including conventional linear measurements as well as area-
based measurements or volumetric estimates, should be jointly
considered for diagnosing and documenting LV dilation and systolic
dysfunction in horses.
In conclusion, this study defines reference intervals for a variety
of uni-, 2-, and 3-dimensional echocardiographic indices of LV size
and function in Warmblood horses and demonstrates that measure-
ment variability is sufficiently low for clinical use of all variables. Allo-
metric scaling appears to be effective and practical to correct diastolic
LV dimensions and CO for differences in body size within breed. In
clinical practice, systolic LV dimensions, variables representing wall
thickness and fractional changes of LV internal dimensions may not
need correction due to minor influence of BWT on these variables.
Scaling to a BWT of 500 kg is preferred over aortic indexing for
assessing diastolic LV size. Various echocardiographic indices can
result in different conclusions with regard to identification of LV
enlargement and systolic dysfunction in horses with mitral and aortic
regurgitation, suggesting that assessment of LV size and function
should be based on an integrative approach of subjective evaluation
and joint assessment of a combination of multiple uni- and multi-
dimensional measurements and indices. Importantly, variables that
reflect LV long-axis motion should be included for comprehensive
assessment of LV function.
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